Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 11, 2000, Pages 4331-4337

  Azizi, M ^a   Hallouin, M ^a   Jeunemaitre, X ^a   Guyene, T T ^a   Menard J ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSINOGEN; ENALAPRILAT; ETHINYLESTRADIOL; PLACEBO; REMIKIREN; RENIN; RENIN INHIBITOR;

ADULT; ALLELISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MATERNAL HYPERTENSION; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANGIOTENSINOGEN; CAPTOPRIL; ETHINYL ESTRADIOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRANCE; FUROSEMIDE; GENOTYPE; HOMOZYGOTE; HUMANS; KINETICS; MALE; POLYMORPHISM, GENETIC; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0034527682     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.11.4331     Document Type: Article

References (32)

1. Oral contraceptives. Renin, aldosterone, and high blood pressure
2. Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration and substrate
3. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives
4. Studies on angiotensinogen formation in a liver perfusion system
5. Kinetic studies of the human renin and human substrate reaction
6. Comparative enzymatic studies of human renin acting on pure natural or synthetic substrates
7. Oral contraceptive and hypertension
8. Influence of diethylstilbestrol on the renin-angiotensin system of male rats
9. A possible mechanism for hypertension induced by oral contraceptives. Diminished feedback suppression of renin release
10. Molecular basis of human hypertension: Role of angiotensinogen
11. Molecular genetics of human hypertension: Role of angiotensinogen
12. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro
13. Angiotensinogen T235 expression is elevated in decidual spiral arteries
14. A(-6)G variant of angiotensinogen gene and aldosterone levels in hypertensives
15. Angiotensinogen gene polymorphism near transcription start site and blood pressure: Role of a T-to-C transition at intron I
16. In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II
17. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I
18. Direct radioimmunoassay of active renin in human plasma
19. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody
20. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives
21. Haplotypes of angiotensinogen in essential hypertension
22. Comparison of pharmacodynamic properties of various estrogen formulations
23. Differential regulation of angiotensin peptides in plasma and kidney; effects of adrenalectomy and estrogen treatment
24. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women
25. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population
26. Plasma levels and pharmacokinetics of ethynyl estrogens in various populations. I. Ethynylestradiol
27. Sulphation of contraceptive steroids
28. Factors affecting the enterohepatic circulation of oral contraceptive steroids
29. Fat tissue; a steroid reservoir and site of steroid metabolism
30. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels
31. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity
32. Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women